Elocon 0.1% scalp lotion

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Mometasone furoate

Available from:

Organon Pharma (UK) Ltd

ATC code:

D07AC13

INN (International Name):

Mometasone furoate

Dosage:

1mg/1gram

Pharmaceutical form:

Cutaneous liquid

Administration route:

Cutaneous

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 13040000; GTIN: 5012376019734

Patient Information leaflet

PACKAGE LEAFLET: INFORMATION FOR THE USER
ELOCON® SCALP LOTION
Mometasone Furoate
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor, pharmacist or
nurse.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any
possible side effects not listed in this leaflet. See Section 4.
WHAT IS IN THIS LEAFLET:
1.
What Elocon is and what it is used for
2.
What you need to know before you use Elocon
3.
How to use Elocon
4.
Possible side effects
5.
How to store Elocon
6.
Contents of the pack and other information
1.
WHAT ELOCON IS AND WHAT IT IS USED FOR
Elocon Scalp Lotion is one of a group of medicines called topical
corticosteroids. It is classified
as a “potent corticosteroid”. These medicines are put on the
surface of the skin to reduce the
redness and itchiness caused by certain skin problems.
In adults and children, Elocon Scalp Lotion is used to reduce redness
and itchiness caused by
certain conditions affecting the scalp, called psoriasis or
dermatitis.
Psoriasis is a skin disease in which itchy, scaly, pink patches
develop on the elbows, knees, scalp
and other parts of the body. Dermatitis is a condition brought on by
the skin reacting to outside
agents e.g. detergents, causing the skin to become red and itchy.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE ELOCON
Do not use Elocon if you have any of the following:

Allergies (hypersensitivity) to mometasone furoate, or any of the
other ingredients of this
medicine (listed in section 6) or to other similar medicines

Scalp problems as it could make them worse

Chickenpox

Shingles

Warts

Other skin infections

Ulcerated skin

Wounds

Skin atrophy (thinning of the skin)
Ask your

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Elocon 0.1% w/w Scalp Lotion
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Mometasone furoate 0.1% w/w
Excipient with known effect
Propylene glycol 30.0% w/w
For full list of excipients see section 6.1.
3
PHARMACEUTICAL FORM
Lotion
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Elocon Scalp Lotion is indicated for the treatment of inflammatory and
pruritic
manifestations of psoriasis and seborrhoeic dermatitis of the scalp.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Adults, including elderly patients and Children : _A few drops of
Elocon Scalp
Lotion should be applied to affected scalp sites, once daily; massage
gently
and thoroughly until the medication disappears.
Use of topical corticosteroids in children should be limited to the
least amount
compatible with an effective therapeutic regimen and duration of
treatment
should be no more than 5 days.
4.3
CONTRAINDICATIONS
Elocon Scalp Lotion is contraindicated in skin atrophy, bacterial
(e.g.
impetigo, pyodermas), viral (e.g. herpes simplex, herpes zoster and
chickenpox, verrucae vulgares, condylomata acuminata, molluscum
contagiosum) parasitical and fungal (e.g. candida or dermatophyte)
infections
of the scalp. Elocon should not be used on wounds or on skin which is
ulcerated. Elocon Scalp Lotion should not be used in patients who are
sensitive to mometasone furoate or to other corticosteroids or to any
of the
excipients listed in section 6.1.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
If irritation or sensitisation develop with the use of Elocon,
treatment should
be withdrawn and appropriate therapy instituted.
Should an infection develop, use of an appropriate antifungal or
antibacterial
agent should be instituted. If a favourable response does not occur
promptly,
the corticosteroid should be discontinued until the infection is
adequately
controlled.
Systemic absorption of topical corticosteriods can produce reversible
hypothalamic-pituitary-adrenal (HPA) axis suppression with the
potential f